851. The Rectal Mucosal Immune Environment and HIV Transmission: Target cells, Inflammation, and the Microbiome
Session: Symposium: The Human Microbiome in HIV
Thursday, October 4, 2018: 2:00 PM
Room: S 305-314
Colleen Kelley, MD, MPH, Medicine, Division of Infectious Diseases, Emory University, Decatur, GA

Dr. Kelley is Associate Professor of Medicine at Emory University School of Medicine in the Division of Infectious Diseases with a multi-disciplinary background and previous experience in clinical HIV medicine, HIV epidemiology and clinical outcomes research, and laboratory based HIV research. She completed medical school and a Masters of Public Health at Emory University, Internal Medicine residency at UCSF, and Infectious Diseases fellowship at Emory University. The focus of Dr. Kelley's research is on biomedical HIV prevention interventions and translational immunology studies of rectal mucosal HIV susceptibility. The overarching goal of her research is to optimize efficacy of biomedical HIV prevention interventions for populations at high risk of infection through a better understanding of mucosal HIV transmission. To facilitate this work, Dr. Kelley developed a successful translational immunology program at Emory focused on rectal HIV transmission among at-risk populations. She is currently principal investigator of several ongoing, federally funded studies focused on examining the influence of human sexual contexts on rectal mucosal susceptibility to HIV among men who have sex with men.


Disclosures:

C. Kelley, Gilead Sciences: Research Contractor , Research grant .

See more of: The Human Microbiome in HIV
See more of: Symposium
Previous Presentation | Next Presentation >>

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.